Business Wire

Boehringer Ingelheim and Oxford BioTherapeutics Expand Collaboration to Discover Novel Selective Tumor Targets as First Bispecific Antibody Advanced into the Clinic

Share

Boehringer Ingelheim and Oxford BioTherapeutics Ltd. (OBT) today announced they are building on their successful partnership and are establishing a new alliance to discover additional selective targets for strategic cancer indications to deliver first-in-class treatments for cancer patients. Boehringer Ingelheim will use OBT’s OGAP® platform to identify novel target opportunities for new immunotherapies utilizing their T-cell engager, cancer vaccine and oncolytic virus platforms. This follows the initiation of the first patient dosing in a Phase 1 clinical trial of a bispecific antibody for the treatment of patients with small cell lung carcinoma and other neoplasms, where the target for the bispecific antibody was discovered during the first phase of the partnership.

“This collaboration with Oxford BioTherapeutics is important for advancing therapeutic modalities that depend upon the identification of unique and specific tumor antigens within our cancer immunology portfolio,” said Jonathon Sedgwick, Ph.D., Senior Vice President and Global Head Cancer Immunology & Immune Modulation Research at Boehringer Ingelheim. “We are committed to developing innovative, efficacious and safe treatment options for patients suffering from cancer, and these novel cancer target discoveries are a key step in the development of new potential treatments.”

“We view the hopeful discovery of additional tumor targets as further confirmation of the value of our OGAP® platform to identify novel targets that can be substrates for innovative new therapies,” said Christian Rohlff, Ph.D., Chief Executive Officer of OBT. “OBT’s platforms are designed to discover and validate novel therapeutic targets and we look forward to continuing our partnership with Boehringer Ingelheim to best address difficult-to-treat cancers.”

In addition to the programs in the partnership with Boehringer Ingelheim, OBT’s clinical assets have also been enabled through the OGAP® discovery platform. Selecting the right target is fundamental for the successful development of a truly first-in-class oncology product. OBT’s platforms are designed to discover novel therapeutic targets and engineer antibodies to those targets, including CAR-T, other T-cell and NK cell-mediated cytotoxicity (ADCC) therapeutics to best address difficult-to-treat cancers. A major differentiator between OBTs discovery platform and other approaches is the retention of the link between individual patient samples through to the design of therapeutic antibodies and diagnostic patient selection tools, increasing the overall successful transition into clinical development.

Financial terms of the expanded agreement are not being disclosed. Under the terms of the agreement, Boehringer Ingelheim is responsible for the development and commercialization of antibody product candidates that interact with the novel targets identified by OGAP®. OBT will receive development and regulatory milestone payments and royalties on any future product sales. To date, Boehringer Ingelheim has exercised two options under the first agreement and has selected two therapeutic candidates for further development.

Boehringer Ingelheim Oncology is taking cancer on by leading the science with cancer cell directed agents, immuno-oncology therapies and their combinations to address unmet needs in lung and gastrointestinal cancers. The company invests significantly in early stage research to identify unexplored and undrugged pathways of cancer. Learn more about Boehringer Ingelheim’s innovation in oncology here.

Please click on the following link for ‘Notes to Editors’:
http://www.boehringer-ingelheim.com/press-release/collaboration-oxfordbiotherapeutics

Contact information

Media Contacts:
Dr. Reinhard Malin
Head of Communications Innovation Unit
Boehringer Ingelheim Corporate Center GmbH
Media + PR
P: +49 6132 77-90815
reinhard.malin@boehringer-ingelheim.com

Linda Ruckel
Senior Associate Director, Media and Corporate Reputation
Boehringer Ingelheim U.S.
Media + PR
P: +1 203-791-6672
linda.ruckel@boehringer-ingelheim.com

Contacts for OBT
Investors:
Lee Roth
212-213-0006, ext. 331
lroth@burnsmc.com

Media:
Ryo Imai / Robert Flamm, Ph.D.
212-213-0006, ext. 315 / 364
rimai@burnsmc.com / rflamm@burnsmc.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Verimatrix Video Content Security Expert to Speak at SportsPro Asia Virtual Summit20.10.2020 18:45:00 EESTPress release

Regulatory News: Verimatrix, (Paris:VMX) (Euronext Paris: VMX), the leader in powering the modern connected world with people-centered security, today announced that Christopher Rae, Senior Vice President of Sales for Asia Pacific, is scheduled to speak during a SportsPro Asia panel discussion at 4 p.m. SGT on Thursday, October 22. Titled, “Reimagining the Fan Experience: Maximizing Opportunities Through Digital”, the panel is set to discuss how OTT and digital bring the promise of personalized, responsive viewer experiences that go far beyond those of linear broadcast platforms. The panel will also discuss the latest piracy threats and challenges associated with launching new streaming services in different Asian markets. Rae’s fellow panelists include: Jay Ganesan, Senior Vice President and Region Head for Asia Pacific at MediaKind Oliver Duss, Executive Vice President, Media, at Football Marketing Asia (FMA) Eoin Connolly, Editor At Large at SportsPro SportsPro Asia provides attende

Nexeo Plastics Signs Distribution Agreement in Europe with Kingfa20.10.2020 17:06:00 EESTPress release

Nexeo Plastics, a leading global thermoplastics resin distributor, has signed an agreement with Kingfa to distribute their engineering thermoplastic products throughout Europe. Effective immediately, Nexeo Plastics will carry and distribute Kingfa’s locally made compounds. Each product group offers a wide range of color-matching options and innate characteristics to improve manufacturing and end-product functionality. This includes an array of choices in unfilled, talc-filled, reinforced, toughened, flame-retardant and recycled compounds. “We look forward to partnering with Nexeo Plastics to expand our footprint in Europe and reach new customers who are seeking high-quality, customized compounding solutions,” said Dr. D.H. Sun, managing director of Kingfa Europe. Kingfa, a preeminent leader in the research, production and sales of advanced polymer materials, has European facilities in Wiesbaden, Germany, serving the EMEA region. The location includes an advanced technology production p

Brookfield Renewable Ireland Selects PCI’s Enterprise Cloud Platform to Meet its Energy Billing Requirements20.10.2020 17:00:00 EESTPress release

Brookfield Renewable Ireland has selected PCI’s Enterprise Platform for management of its energy billing requirements in the Irish power market. As part of its agreement with Brookfield Renewable Ireland, PCI will deploy its specifically tailored, cloud-based, integrated platform that incorporates the PCI Billing Solution, and a breadth of capabilities including: Management of complex bilateral contracts, such as power purchase agreements (PPA) Contract settlements calculation engine to perform settlement allocation based on specific business rules Interfaces with upstream and downstream systems Comprehensive auditability with all data versions and updates stored for auditing requirements Extensive workflow automation for invoice creation and management Data extraction, reporting and drill-down capabilities Platform extension to support Brookfield Renewable Ireland’s customer portal Chief Commercial Officer at Brookfield Renewable Ireland, Ciaran O'Brien noted, “To support our business

Goldman Sachs Merchant Banking Division Partners With Leading Data Infrastructure Management Team and Commits up to $500 Million to Form Data Center Platform, Global Compute20.10.2020 17:00:00 EESTPress release

The Goldman Sachs Merchant Banking Division (“GS MBD”) today announced that it has partnered with a seasoned management team, led by long-time data center industry executive Scott Peterson, to form Global Compute Infrastructure LP (“Global Compute” or the “Company”), a newly established global data center infrastructure platform. GS MBD has initially committed to fund up to $500 million of equity capital, primarily from its infrastructure fund, West Street Infrastructure Partners III, LP (“WSIP III”), to enable approximately $1.5 billion in near-term investments deployed across North America, Europe, Asia Pacific and Latin America. Global Compute intends to grow through a combination of acquisitions and organic development to serve customers in geographies with strong secular tailwinds and potential for significant data infrastructure growth. Leveraging the experience and track record of the management team, Global Compute will focus on acquiring and developing facilities which can mee

Andersen Global Signs Collaboration Agreement with Belarus’ Largest Law Firm20.10.2020 16:30:00 EESTPress release

Andersen Global expands its platform in Eastern Europe with the addition of collaborating firm REVERA, one of the top tier law firms in Belarus, broadening the organization’s coverage as it bolsters its foothold in the region. Founded in 1998, the Minsk-based firm provides corporate, commercial, litigation, labor, antitrust, real estate and intellectual property law, focusing on tax and private client services. Led by Managing Partner Dmitry Arkhipenko, REVERA’s team of more than 50 lawyers represents a number of multinational companies and often participates in Belarus’ legislative process. Additionally, the firm has been recognized by Chambers Europe, Legal 500, IFLR 100 and Best Lawyers. “For over 20 years, our firm has built a respectable reputation through our commitment to stewardship and independence, and our ability to provide clients with best-in-class solutions,” Dmitry said. “We look forward to working with the member firms and collaborating firms of Andersen Global as we co

The 26th China Yiwu International Commodities (Standards) Fair to Kick Off This Month With More Activities to Promote Trade20.10.2020 16:21:00 EESTPress release

The 26th China Yiwu International Commodities (Standards) Fair ("Yiwu Fair") will be held at Yiwu International Expo Center on October 21-25, 2020. Founded in 1995 and as one of the three export exhibitions sponsored by China’s Ministry of Commerce, Yiwu Fair is now the largest, most influential, and most effective daily necessities exhibition in China. Yiwu Fair 2020 will be China’s first large-scale foreign trade exhibition presented both online and offline in the wake of the pandemic. It is expected to attract more than 50,000 professional buyers, with 3,400 international standard booths, covering hardware, electromechanical facilities, electronic & electrical appliances, daily necessities, crafts & ornaments, stationery & office goods, toys, sporting & outdoor products, knitwear, and gift packaging. This year, Yiwu Fair will invite around 10 delegations or 1,600 persons from foreign trade organizations and representative offices based in China, and nearly 20 delegations or 1,800 bu

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom